Lite Strategy, Inc. (LITS)

NASDAQ·Healthcare·Biotechnology

$1.18

+1.73%

Mkt Cap $41.51M

No analyst coverage available

We don't have analyst ratings or price target data for Lite Strategy, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.